Viome offers at-home testing kits that analyze biological samples to provide users with health insights. Viome This article is part of " Build IT: Connectivity ," a series about tech powering better business. Viome is aiming to transform disease detection, starting with the gut. The Washington-based biotech startup offers at-home testing kits that analyze saliva, stool, and blood samples. Using RNA analysis, scientists at Viome can evaluate how genes and gut microbes are behaving in real time. Once the tests are done, AI is applied to the results to generate personalized food and supplement recommendations. Users might be told to avoid spinach to reduce inflammation or take specific probiotics to support digestion and immunity. So far, the company said it has sold more than half a million testing kits. Backed by Salesforce CEO Marc Benioff and venture capital firm Khosla Ventures, Viome is now scaling its tools to detect early signs of disease, including oral and thro...